Your browser doesn't support javascript.
loading
Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs).
Besheer, Ahmed; Mahler, Hanns-Christian; Matter-Schwald, Anja; Barrenechea, Sergio Mompart; Vogt, Martin; Chalus, Pascal; Heymes, Pauline; Pillow, Timothy; Kirste, Andrea; Favrod, Patrick; Joerg, Susanne; Mathaes, Roman.
Afiliación
  • Besheer A; Lonza Drug Product Services, Basel, Switzerland. ahmed.besheer@lonza.com.
  • Mahler HC; Lonza Drug Product Services, Basel, Switzerland.
  • Matter-Schwald A; Lonza Drug Product Services, Basel, Switzerland.
  • Barrenechea SM; Lonza Drug Product Services, Basel, Switzerland.
  • Vogt M; Lonza Drug Product Services, Basel, Switzerland.
  • Chalus P; Lonza Drug Product Services, Basel, Switzerland.
  • Heymes P; Lonza Drug Product Services, Basel, Switzerland.
  • Pillow T; Lonza Drug Product Services, Basel, Switzerland.
  • Kirste A; Lonza Drug Product Services, Basel, Switzerland.
  • Favrod P; Lonza Drug Product Services, Basel, Switzerland.
  • Joerg S; Lonza Drug Product Services, Basel, Switzerland.
  • Mathaes R; Lonza Drug Product Services, Basel, Switzerland. roman.mathaes@lonza.com.
Pharm Res ; 37(4): 81, 2020 Apr 09.
Article en En | MEDLINE | ID: mdl-32274594
ABSTRACT

PURPOSE:

Health care professionals can be exposed to hazardous drugs such as cytostatics during preparation of drugs for administration. Closed sytem transfer devices (CSTDs) were introduced to provide protection for healthcare professional against unintended exposure to hazardous drugs. The interest in CSTDs has significantly increased after USP <800> monograph was issued. The majority of the studies published so far on CSTDs have focused on their "containment" function. However, other important attributes for CSTDs with potential importance for product quality impact are not yet fully evaluated.

METHODS:

In the current study, we evaluated four sytems from different suppliers, in combination with different container closure systems (CCS), using solutions of different viscosity and surface tension. The different CSTD / CCS combinations were tested for (a) containment (integrity) using a highly sensitive helium leak test, (b) the force required for mounting the vial adaptor, (c) contribution to visible and subvisible particles as well as (d) the hold-up volume.

RESULTS:

Results show that the majority of CSTDs may have leaks varying in size, and that some of them generated visible particles due to stopper coring and subvisible particles, both due to silicon oil and particulate contaminations of the Devices. Finally, the holdup volume was up to 1 mL depending on the CSTD type, vial size and solution viscosity.

CONCLUSION:

These results show that there is a need to evaluate the compatibility of CSTD systems to select the best system for the intended use and that CSTDs may adversely impact product quality and delivered dose.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Equipos de Seguridad / Preparaciones Farmacéuticas / Exposición Profesional / Personal de Salud / Embalaje de Medicamentos / Almacenaje de Medicamentos Límite: Humans Idioma: En Revista: Pharm Res Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Equipos de Seguridad / Preparaciones Farmacéuticas / Exposición Profesional / Personal de Salud / Embalaje de Medicamentos / Almacenaje de Medicamentos Límite: Humans Idioma: En Revista: Pharm Res Año: 2020 Tipo del documento: Article País de afiliación: Suiza